A detailed history of Schonfeld Strategic Advisors LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 1,058,100 shares of RVPH stock, worth $1.66 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,058,100
Previous 1,515,900 30.2%
Holding current value
$1.66 Million
Previous $2.18 Million 16.13%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$0.92 - $2.82 $421,176 - $1.29 Million
-457,800 Reduced 30.2%
1,058,100 $1.83 Million
Q3 2024

Nov 14, 2024

BUY
$0.64 - $1.48 $321,349 - $743,121
502,109 Added 49.53%
1,515,900 $2.18 Million
Q2 2024

Aug 14, 2024

BUY
$1.25 - $3.79 $233,988 - $709,453
187,191 Added 22.65%
1,013,791 $1.3 Million
Q1 2024

May 15, 2024

BUY
$2.76 - $5.52 $2.28 Million - $4.56 Million
826,600 New
826,600 $3.12 Million

Others Institutions Holding RVPH

About REVIVA PHARMACEUTICALS HOLDINGS, INC.


  • Ticker RVPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,442,900
  • Market Cap $32.1M
  • Description
  • Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...
More about RVPH
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.